{"gene":"TOX2","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2019,"finding":"TOX2 (along with TOX) is induced downstream of NFAT in CD8+ T cells stimulated without AP-1, and both transcription factors cooperate to impose the CD8+ T cell exhaustion transcriptional program; dual knockout of TOX and TOX2 in CAR T cells increased chromatin accessibility at NFκB and bZIP motif-containing regions, increased cytokine expression, and decreased inhibitory receptor expression, enhancing antitumor efficacy. Evidence for positive cross-regulation between NR4A and TOX, and TOX and NR4A, was also provided.","method":"CAR T cell mouse model with Tox/Tox2 double knockout, ATAC-seq for chromatin accessibility, flow cytometry for inhibitory receptors and cytokines, in vivo tumor suppression assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean double-KO with defined cellular phenotype, multiple orthogonal methods (ATAC-seq, flow cytometry, in vivo tumor models), high citation count indicating replication","pmids":["31152140"],"is_preprint":false},{"year":2019,"finding":"TOX2 drives T follicular helper (Tfh) cell differentiation by directly binding to chromatin at the Bcl6 locus and other Tfh-associated loci, increasing chromatin accessibility at these sites; ectopic expression of Tox2 was sufficient to induce Bcl6 expression and Tfh development, and Tox2−/− mice showed defective Tfh differentiation. TOX2 and TOX together establish a Tox2–Bcl6 transcriptional feed-forward loop.","method":"ChIP-seq (genome-wide Tox2 occupancy), ATAC-seq (chromatin accessibility), Tox2−/− mice, ectopic overexpression, genetic epistasis with Bcl6","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide ChIP-seq and ATAC-seq combined with genetic KO and overexpression rescue; replicated in vivo, high citation count","pmids":["31732165"],"is_preprint":false},{"year":2014,"finding":"Human TOX2 directly upregulates transcription of TBX21 (encoding T-BET) to control natural killer (NK) cell development; TOX2 knockdown hindered early NK cell developmental transitions from cord blood CD34+ progenitors, while T-BET overexpression rescued the TOX2 knockdown phenotype. TOX2 acts independently of ETS-1 in this pathway.","method":"Gene silencing (shRNA knockdown), overexpression of TOX2 and T-BET, in vitro NK cell differentiation assays from CD34+ cord blood progenitors, genetic epistasis (T-BET rescue of TOX2 KD)","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with rescue experiment and loss-of-function phenotype; single lab but multiple orthogonal methods","pmids":["25352127"],"is_preprint":false},{"year":2021,"finding":"Tox2 is required for maintenance of germinal center (GC) TFH cells and generation of memory TFH cells; Tox2 overexpression maintained TFH-associated gene expression in TCR-stimulated human GC TFH cells and inhibited spontaneous conversion to TH1-like cells, while Tox2-deficient mice displayed impaired secondary TFH cell expansion upon reimmunization or heterologous influenza infection.","method":"Tox2-deficient mice, in vitro Tox2 overexpression in human GC TFH cells, reimmunization and heterologous influenza infection models, gene expression analysis","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with defined cellular phenotype in vivo, overexpression in human cells, multiple experimental contexts","pmids":["34623911"],"is_preprint":false},{"year":2023,"finding":"In Natural Killer/T-cell lymphoma (NKTL), RUNX3 regulates TOX2 transcription by binding to active elements of its super-enhancer; TOX2 in turn drives oncogenesis with metastasis-associated phosphatase PRL-3 as a key downstream effector, establishing a RUNX3–TOX2(SE)–PRL-3 regulatory pathway. shRNA knockdown and CRISPR-dCas9 interference of the super-enhancer impaired cell proliferation, survival, colony formation, and in vivo tumor formation.","method":"ChIP-PCR (RUNX3 binding to TOX2 SE), shRNA knockdown, CRISPR-dCas9 SE interference, luciferase reporter assay, in vivo xenograft tumor model, Nano-ChIP-seq","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP, CRISPR, reporter assay, in vivo), single lab","pmids":["37032358"],"is_preprint":false},{"year":2023,"finding":"TOX2 positively regulates central memory T cell (TCM) differentiation in human CAR T cells by binding to promoters of numerous TCM-associated genes; loss of TET2 increased chromatin accessibility at TOX and TOX2 loci and elevated TOX2 expression, while TOX2 knockdown (in contrast to TOX knockdown) decreased TCM percentage and reduced proliferation, demonstrating that TOX2 functions as a potentiator of memory rather than exclusively an exhaustion factor.","method":"TET2 knockdown followed by ATAC-seq and gene expression analysis; TOX2 shRNA knockdown in human CAR T cells; ChIP-seq for TOX2 binding at TCM gene promoters; flow cytometry for TCM markers","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq plus loss-of-function with defined cellular phenotype; multiple orthogonal methods in single lab","pmids":["37467321"],"is_preprint":false},{"year":2024,"finding":"Tox2 is required for metabolic adaptation and tissue residency of gut ILC3; Tox2-deficient gut ILC3 showed decreased Hexokinase-2 expression and reduced glycolytic capacity for protein translation, leading to impaired gut ILC3 maintenance and defective control of Citrobacter rodentium infection. Ectopic Hexokinase-2 expression rescued Tox2−/− gut ILC3 defects. Hypoxia and IL-17A each induced Tox2 expression in ILC3.","method":"Tox2−/− mice, single-cell transcriptional profiling (scRNA-seq), ectopic Hexokinase-2 overexpression rescue, Citrobacter rodentium infection model, metabolic assays for glycolysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with mechanistic rescue experiment (HK2 overexpression), scRNA-seq, in vivo infection model; multiple orthogonal methods with strong mechanistic specificity","pmids":["38677292"],"is_preprint":false},{"year":2024,"finding":"Nuclear TOX2 and TOX form a protein complex that represses HAVCR2 (TIM3) promoter activity by recruiting the transcriptional corepressor LCOR and deacetylase HDAC3; in contrast, cytoplasmic TOX2 cannot perform this repression. The nuclear-to-cytosol translocation of TOX2 is deacetylation-dependent and cooperatively mediated by deacetylase SIRT1 and kinase TBK1. Knockdown of TOX, TOX2, or LCOR, or HDAC3 inhibition, induced Jurkat cell apoptosis in vitro and slowed tumor growth in vivo.","method":"Co-immunoprecipitation (TOX–TOX2 complex, LCOR and HDAC3 recruitment), luciferase reporter assay (HAVCR2 promoter), shRNA knockdown, SIRT1/TBK1 inhibition/manipulation, subcellular fractionation, in vivo xenograft model","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP for complex identification combined with reporter assay, loss-of-function in vitro and in vivo; single lab","pmids":["39080376"],"is_preprint":false},{"year":2025,"finding":"Genome-wide Calling Cards mapping in primary human CD8+ T cells revealed that TOX2 binds to target loci in human CD8+ T cells; integrative analysis of TOX2 binding with multi-omic data identified putative TOX2 gene targets related to memory and exhaustion states. Domain-swapped TF experiments showed that paralogous TFs display emergent binding site selection behavior not predictable from their constituent domains.","method":"Transposon-based Calling Cards TF mapping in primary human CD8+ T cells, TFlex multiplexed mapping, multi-omic integration (CUT&RUN, ATAC-seq, RNA-seq)","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — genome-wide binding map in primary cells but mechanistic functional validation not yet performed; preprint","pmids":["bio_10.1101_2025.10.09.681414"],"is_preprint":true}],"current_model":"TOX2 is an HMG-box transcription factor that acts downstream of NFAT to cooperate with TOX in imposing CD8+ T cell exhaustion, while also driving Tfh cell differentiation via a Tox2–Bcl6 feed-forward loop, supporting gut ILC3 tissue residency through Hexokinase-2-dependent glycolytic reprogramming, and promoting NK cell development by directly upregulating TBX21; in T-ALL, nuclear TOX2 forms a repressive complex with TOX, LCOR, and HDAC3 to suppress TIM3 (HAVCR2) transcription, with its nuclear-cytosol shuttling controlled by SIRT1-mediated deacetylation and TBK1-dependent phosphorylation."},"narrative":{"teleology":[{"year":2014,"claim":"Establishing TOX2 as a transcription factor active in early lymphocyte development, this work showed that TOX2 directly upregulates TBX21 to control NK cell developmental transitions, a function independent of ETS-1.","evidence":"shRNA knockdown and T-BET rescue in cord blood CD34+ progenitor-derived NK cell differentiation assays","pmids":["25352127"],"confidence":"Medium","gaps":["Direct binding of TOX2 to the TBX21 promoter was not demonstrated by ChIP","Role of TOX2 in mature NK cell function beyond developmental transitions is unknown","Whether TOX2 controls NK development in vivo was not tested"]},{"year":2019,"claim":"Two studies established TOX2 as a key transcriptional regulator in CD4+ and CD8+ T cell fate decisions: in CD8+ T cells, TOX2 cooperates with TOX downstream of NFAT to enforce the exhaustion program, while in CD4+ T cells, TOX2 directly binds the Bcl6 locus to initiate a feed-forward loop driving Tfh differentiation.","evidence":"Tox/Tox2 double-KO CAR T cells with ATAC-seq, flow cytometry, and in vivo tumor models (CD8+ exhaustion); ChIP-seq, ATAC-seq, and Tox2−/− mice with ectopic overexpression (Tfh differentiation)","pmids":["31152140","31732165"],"confidence":"High","gaps":["Whether TOX2 has distinct or redundant chromatin targets compared to TOX was not resolved","The precise DNA-binding specificity of TOX2's HMG-box domain versus TOX was not defined","Relative contributions of TOX versus TOX2 to exhaustion versus memory programs remained unclear"]},{"year":2021,"claim":"Extending the Tfh role, TOX2 was shown to be required not only for initial Tfh differentiation but also for maintaining germinal center Tfh identity and generating durable memory Tfh populations capable of recall responses.","evidence":"Tox2-deficient mice with reimmunization and heterologous influenza infection; Tox2 overexpression in human GC Tfh cells preventing TH1 conversion","pmids":["34623911"],"confidence":"Medium","gaps":["Direct TOX2 chromatin targets in GC Tfh versus pre-Tfh were not distinguished","Whether TOX2 collaborates with the same or different cofactors in GC Tfh maintenance is unknown"]},{"year":2023,"claim":"Two studies reframed TOX2's functional versatility: in NKTL, RUNX3 drives TOX2 expression through a super-enhancer to activate the oncogenic effector PRL-3; separately, in human CAR T cells, loss of TET2 elevates TOX2 expression and TOX2 promotes central memory T cell differentiation by binding TCM gene promoters, distinguishing its memory-promoting role from its exhaustion-associated function.","evidence":"ChIP-PCR, CRISPR-dCas9 SE interference, xenograft models (NKTL); TET2 knockdown with ATAC-seq, TOX2 ChIP-seq, shRNA in human CAR T cells (TCM)","pmids":["37032358","37467321"],"confidence":"Medium","gaps":["Whether the RUNX3–TOX2 super-enhancer axis operates in non-malignant lymphocytes is untested","How TOX2 discriminates between memory versus exhaustion target gene sets is mechanistically undefined","The relationship between TET2-mediated demethylation at the TOX2 locus and TOX2 protein activity is correlative"]},{"year":2024,"claim":"Two advances revealed TOX2 functions in innate lymphoid cells and in leukemic gene repression: in gut ILC3, TOX2 promotes tissue residency by transcriptionally activating Hexokinase-2 to support glycolytic metabolism required for protein translation; in T-ALL, nuclear TOX2 forms a repressive complex with TOX, LCOR, and HDAC3 to suppress HAVCR2 (TIM3), with nuclear-cytoplasmic shuttling controlled by SIRT1-mediated deacetylation and TBK1 phosphorylation.","evidence":"Tox2−/− mice with scRNA-seq, HK2 rescue, and Citrobacter rodentium infection (ILC3); Co-IP, luciferase reporter, shRNA, subcellular fractionation, and xenograft model (T-ALL)","pmids":["38677292","39080376"],"confidence":"High","gaps":["Whether the TOX2–LCOR–HDAC3 repressive complex operates in normal T cells or is specific to T-ALL is unknown","The acetylation sites on TOX2 targeted by SIRT1 have not been mapped","Whether TOX2's glycolytic reprogramming role extends to other tissue-resident lymphocyte populations is untested"]},{"year":null,"claim":"Key unresolved questions include how TOX2's HMG-box domain selects among its diverse target loci in different lineage contexts, the structural basis for TOX2–TOX heterodimerization, and whether TOX2 post-translational modifications (acetylation, phosphorylation) gate its transcriptional outputs in non-malignant lymphocyte subsets.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of TOX2 or the TOX–TOX2 complex exists","Genome-wide binding maps in primary cells lack functional validation of individual target genes","Post-translational regulation of TOX2 has only been studied in T-ALL cells"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,5,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,5,6,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,5,7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,3,6]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,2,5,7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,7]}],"complexes":["TOX–TOX2–LCOR–HDAC3 repressive complex"],"partners":["TOX","BCL6","LCOR","HDAC3","SIRT1","TBK1","RUNX3","TBX21"],"other_free_text":[]},"mechanistic_narrative":"TOX2 is an HMG-box transcription factor that programs lymphocyte identity, persistence, and functional state across multiple immune cell lineages. In CD8+ T cells, TOX2 cooperates with TOX downstream of NFAT to impose the exhaustion transcriptional program—dual knockout of both factors opens chromatin at NFκB and bZIP motifs, restores cytokine production, and enhances antitumor CAR T cell efficacy—yet TOX2 also independently promotes central memory T cell differentiation by binding TCM-associated gene promoters [PMID:31152140, PMID:37467321]. In T follicular helper cells, TOX2 directly binds and activates the Bcl6 locus to establish a feed-forward loop that drives Tfh differentiation and sustains germinal center and memory Tfh populations, while in gut ILC3 it supports tissue residency by transcriptionally upregulating Hexokinase-2 to enable glycolytic metabolic adaptation [PMID:31732165, PMID:34623911, PMID:38677292]. In the nucleus of T-ALL cells, TOX2 forms a repressive complex with TOX, the corepressor LCOR, and the deacetylase HDAC3 to suppress HAVCR2 (TIM3) transcription, with its nuclear retention regulated by SIRT1-mediated deacetylation and TBK1-dependent phosphorylation [PMID:39080376]."},"prefetch_data":{"uniprot":{"accession":"Q96NM4","full_name":"TOX high mobility group box family member 2","aliases":["Granulosa cell HMG box protein 1","GCX-1"],"length_aa":488,"mass_kda":51.6,"function":"Putative transcriptional activator involved in the hypothalamo-pituitary-gonadal system","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96NM4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TOX2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TOX2","total_profiled":1310},"omim":[{"mim_id":"611163","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2","url":"https://www.omim.org/entry/611163"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":46.7}],"url":"https://www.proteinatlas.org/search/TOX2"},"hgnc":{"alias_symbol":["dJ1108D11.2","GCX-1"],"prev_symbol":["C20orf100"]},"alphafold":{"accession":"Q96NM4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NM4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NM4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NM4-F1-predicted_aligned_error_v6.png","plddt_mean":51.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOX2","jax_strain_url":"https://www.jax.org/strain/search?query=TOX2"},"sequence":{"accession":"Q96NM4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96NM4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96NM4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NM4"}},"corpus_meta":[{"pmid":"31152140","id":"PMC_31152140","title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31152140","citation_count":613,"is_preprint":false},{"pmid":"31732165","id":"PMC_31732165","title":"The Transcription Factor Tox2 Drives T Follicular Helper Cell Development via Regulating Chromatin Accessibility.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31732165","citation_count":134,"is_preprint":false},{"pmid":"8672886","id":"PMC_8672886","title":"Chromosomal organization of TOX2, a complex locus controlling host-selective toxin biosynthesis in Cochliobolus carbonum.","date":"1996","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/8672886","citation_count":70,"is_preprint":false},{"pmid":"25352127","id":"PMC_25352127","title":"TOX2 regulates human natural killer cell development by controlling T-BET expression.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25352127","citation_count":64,"is_preprint":false},{"pmid":"34623911","id":"PMC_34623911","title":"Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34623911","citation_count":33,"is_preprint":false},{"pmid":"35111387","id":"PMC_35111387","title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.","date":"2022","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/35111387","citation_count":29,"is_preprint":false},{"pmid":"37032358","id":"PMC_37032358","title":"Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.","date":"2023","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37032358","citation_count":27,"is_preprint":false},{"pmid":"28153336","id":"PMC_28153336","title":"Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder.","date":"2016","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28153336","citation_count":24,"is_preprint":false},{"pmid":"11860263","id":"PMC_11860263","title":"An extended physical map of the TOX2 locus of Cochliobolus carbonum required for biosynthesis of HC-toxin.","date":"2002","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/11860263","citation_count":24,"is_preprint":false},{"pmid":"37467321","id":"PMC_37467321","title":"TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37467321","citation_count":23,"is_preprint":false},{"pmid":"8918240","id":"PMC_8918240","title":"Transposon-like sequences at the TOX2 locus of the plant-pathogenic fungus Cochliobolus carbonum.","date":"1996","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8918240","citation_count":20,"is_preprint":false},{"pmid":"10656588","id":"PMC_10656588","title":"Reduced virulence caused by meiotic instability of the TOX2 chromosome of the maize pathogen Cochliobolus carbonum.","date":"2000","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/10656588","citation_count":18,"is_preprint":false},{"pmid":"38677292","id":"PMC_38677292","title":"Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut.","date":"2024","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/38677292","citation_count":15,"is_preprint":false},{"pmid":"37011499","id":"PMC_37011499","title":"Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37011499","citation_count":9,"is_preprint":false},{"pmid":"35378414","id":"PMC_35378414","title":"Two hydroxyflavanones isolated from Scutellaria baicalensis roots prevent colitis-associated colon cancer in C57BL/6 J mice by inhibiting programmed cell death-1, interleukin 10, and thymocyte selection-associated high mobility group box proteins TOX/TOX2.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35378414","citation_count":8,"is_preprint":false},{"pmid":"16535561","id":"PMC_16535561","title":"Polymorphic Chromosomes Bearing the Tox2 Locus in Cochliobolus carbonum Behave as Homologs during Meiosis.","date":"1997","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16535561","citation_count":6,"is_preprint":false},{"pmid":"39080376","id":"PMC_39080376","title":"TOX2 nuclear-cytosol translocation is linked to leukemogenesis of acute T-cell leukemia by repressing TIM3 transcription.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/39080376","citation_count":5,"is_preprint":false},{"pmid":"39766129","id":"PMC_39766129","title":"Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks.","date":"2024","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/39766129","citation_count":3,"is_preprint":false},{"pmid":"36990263","id":"PMC_36990263","title":"Acertannin prevents azoxymethane/dextran sulfate sodium-induced colon cancer growth by inhibiting the colonic expression of interleukin-1β, monocyte chemoattractant protein-1, cyclooxygenase-2, and thymocyte selection-associated high mobility group box proteins (TOX)/TOX2 in C57BL/6J mice.","date":"2023","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36990263","citation_count":2,"is_preprint":false},{"pmid":"41020836","id":"PMC_41020836","title":"The TOX2 Gene Is Responsible for Conidiation and Full Virulence in Fusarium pseudograminearum.","date":"2025","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/41020836","citation_count":0,"is_preprint":false},{"pmid":"8604230","id":"PMC_8604230","title":"[Genetic analysis of Vibrio cholerae chromosomal regions containing the tox-2 mutation, affecting production of cholera toxin].","date":"1995","source":"Molekuliarnaia genetika, mikrobiologiia i virusologiia","url":"https://pubmed.ncbi.nlm.nih.gov/8604230","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.09.681414","title":"Scalable transcription factor mapping uncovers the regulatory dynamics of natural and synthetic transcription factors in human T cell states","date":"2025-10-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.09.681414","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.10.681694","title":"Obesity Impairs the Antitumor Activity of CAR-T Cells in Triple-Negative Breast Cancer","date":"2025-10-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.10.681694","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13770,"output_tokens":2821,"usd":0.041813},"stage2":{"model":"claude-opus-4-6","input_tokens":6157,"output_tokens":2311,"usd":0.13284},"total_usd":0.174653,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX2 (along with TOX) is induced downstream of NFAT in CD8+ T cells stimulated without AP-1, and both transcription factors cooperate to impose the CD8+ T cell exhaustion transcriptional program; dual knockout of TOX and TOX2 in CAR T cells increased chromatin accessibility at NFκB and bZIP motif-containing regions, increased cytokine expression, and decreased inhibitory receptor expression, enhancing antitumor efficacy. Evidence for positive cross-regulation between NR4A and TOX, and TOX and NR4A, was also provided.\",\n      \"method\": \"CAR T cell mouse model with Tox/Tox2 double knockout, ATAC-seq for chromatin accessibility, flow cytometry for inhibitory receptors and cytokines, in vivo tumor suppression assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double-KO with defined cellular phenotype, multiple orthogonal methods (ATAC-seq, flow cytometry, in vivo tumor models), high citation count indicating replication\",\n      \"pmids\": [\"31152140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX2 drives T follicular helper (Tfh) cell differentiation by directly binding to chromatin at the Bcl6 locus and other Tfh-associated loci, increasing chromatin accessibility at these sites; ectopic expression of Tox2 was sufficient to induce Bcl6 expression and Tfh development, and Tox2−/− mice showed defective Tfh differentiation. TOX2 and TOX together establish a Tox2–Bcl6 transcriptional feed-forward loop.\",\n      \"method\": \"ChIP-seq (genome-wide Tox2 occupancy), ATAC-seq (chromatin accessibility), Tox2−/− mice, ectopic overexpression, genetic epistasis with Bcl6\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide ChIP-seq and ATAC-seq combined with genetic KO and overexpression rescue; replicated in vivo, high citation count\",\n      \"pmids\": [\"31732165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Human TOX2 directly upregulates transcription of TBX21 (encoding T-BET) to control natural killer (NK) cell development; TOX2 knockdown hindered early NK cell developmental transitions from cord blood CD34+ progenitors, while T-BET overexpression rescued the TOX2 knockdown phenotype. TOX2 acts independently of ETS-1 in this pathway.\",\n      \"method\": \"Gene silencing (shRNA knockdown), overexpression of TOX2 and T-BET, in vitro NK cell differentiation assays from CD34+ cord blood progenitors, genetic epistasis (T-BET rescue of TOX2 KD)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with rescue experiment and loss-of-function phenotype; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25352127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tox2 is required for maintenance of germinal center (GC) TFH cells and generation of memory TFH cells; Tox2 overexpression maintained TFH-associated gene expression in TCR-stimulated human GC TFH cells and inhibited spontaneous conversion to TH1-like cells, while Tox2-deficient mice displayed impaired secondary TFH cell expansion upon reimmunization or heterologous influenza infection.\",\n      \"method\": \"Tox2-deficient mice, in vitro Tox2 overexpression in human GC TFH cells, reimmunization and heterologous influenza infection models, gene expression analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined cellular phenotype in vivo, overexpression in human cells, multiple experimental contexts\",\n      \"pmids\": [\"34623911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In Natural Killer/T-cell lymphoma (NKTL), RUNX3 regulates TOX2 transcription by binding to active elements of its super-enhancer; TOX2 in turn drives oncogenesis with metastasis-associated phosphatase PRL-3 as a key downstream effector, establishing a RUNX3–TOX2(SE)–PRL-3 regulatory pathway. shRNA knockdown and CRISPR-dCas9 interference of the super-enhancer impaired cell proliferation, survival, colony formation, and in vivo tumor formation.\",\n      \"method\": \"ChIP-PCR (RUNX3 binding to TOX2 SE), shRNA knockdown, CRISPR-dCas9 SE interference, luciferase reporter assay, in vivo xenograft tumor model, Nano-ChIP-seq\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, CRISPR, reporter assay, in vivo), single lab\",\n      \"pmids\": [\"37032358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TOX2 positively regulates central memory T cell (TCM) differentiation in human CAR T cells by binding to promoters of numerous TCM-associated genes; loss of TET2 increased chromatin accessibility at TOX and TOX2 loci and elevated TOX2 expression, while TOX2 knockdown (in contrast to TOX knockdown) decreased TCM percentage and reduced proliferation, demonstrating that TOX2 functions as a potentiator of memory rather than exclusively an exhaustion factor.\",\n      \"method\": \"TET2 knockdown followed by ATAC-seq and gene expression analysis; TOX2 shRNA knockdown in human CAR T cells; ChIP-seq for TOX2 binding at TCM gene promoters; flow cytometry for TCM markers\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus loss-of-function with defined cellular phenotype; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"37467321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Tox2 is required for metabolic adaptation and tissue residency of gut ILC3; Tox2-deficient gut ILC3 showed decreased Hexokinase-2 expression and reduced glycolytic capacity for protein translation, leading to impaired gut ILC3 maintenance and defective control of Citrobacter rodentium infection. Ectopic Hexokinase-2 expression rescued Tox2−/− gut ILC3 defects. Hypoxia and IL-17A each induced Tox2 expression in ILC3.\",\n      \"method\": \"Tox2−/− mice, single-cell transcriptional profiling (scRNA-seq), ectopic Hexokinase-2 overexpression rescue, Citrobacter rodentium infection model, metabolic assays for glycolysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic rescue experiment (HK2 overexpression), scRNA-seq, in vivo infection model; multiple orthogonal methods with strong mechanistic specificity\",\n      \"pmids\": [\"38677292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nuclear TOX2 and TOX form a protein complex that represses HAVCR2 (TIM3) promoter activity by recruiting the transcriptional corepressor LCOR and deacetylase HDAC3; in contrast, cytoplasmic TOX2 cannot perform this repression. The nuclear-to-cytosol translocation of TOX2 is deacetylation-dependent and cooperatively mediated by deacetylase SIRT1 and kinase TBK1. Knockdown of TOX, TOX2, or LCOR, or HDAC3 inhibition, induced Jurkat cell apoptosis in vitro and slowed tumor growth in vivo.\",\n      \"method\": \"Co-immunoprecipitation (TOX–TOX2 complex, LCOR and HDAC3 recruitment), luciferase reporter assay (HAVCR2 promoter), shRNA knockdown, SIRT1/TBK1 inhibition/manipulation, subcellular fractionation, in vivo xenograft model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP for complex identification combined with reporter assay, loss-of-function in vitro and in vivo; single lab\",\n      \"pmids\": [\"39080376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Genome-wide Calling Cards mapping in primary human CD8+ T cells revealed that TOX2 binds to target loci in human CD8+ T cells; integrative analysis of TOX2 binding with multi-omic data identified putative TOX2 gene targets related to memory and exhaustion states. Domain-swapped TF experiments showed that paralogous TFs display emergent binding site selection behavior not predictable from their constituent domains.\",\n      \"method\": \"Transposon-based Calling Cards TF mapping in primary human CD8+ T cells, TFlex multiplexed mapping, multi-omic integration (CUT&RUN, ATAC-seq, RNA-seq)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — genome-wide binding map in primary cells but mechanistic functional validation not yet performed; preprint\",\n      \"pmids\": [\"bio_10.1101_2025.10.09.681414\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"TOX2 is an HMG-box transcription factor that acts downstream of NFAT to cooperate with TOX in imposing CD8+ T cell exhaustion, while also driving Tfh cell differentiation via a Tox2–Bcl6 feed-forward loop, supporting gut ILC3 tissue residency through Hexokinase-2-dependent glycolytic reprogramming, and promoting NK cell development by directly upregulating TBX21; in T-ALL, nuclear TOX2 forms a repressive complex with TOX, LCOR, and HDAC3 to suppress TIM3 (HAVCR2) transcription, with its nuclear-cytosol shuttling controlled by SIRT1-mediated deacetylation and TBK1-dependent phosphorylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TOX2 is an HMG-box transcription factor that programs lymphocyte identity, persistence, and functional state across multiple immune cell lineages. In CD8+ T cells, TOX2 cooperates with TOX downstream of NFAT to impose the exhaustion transcriptional program—dual knockout of both factors opens chromatin at NFκB and bZIP motifs, restores cytokine production, and enhances antitumor CAR T cell efficacy—yet TOX2 also independently promotes central memory T cell differentiation by binding TCM-associated gene promoters [PMID:31152140, PMID:37467321]. In T follicular helper cells, TOX2 directly binds and activates the Bcl6 locus to establish a feed-forward loop that drives Tfh differentiation and sustains germinal center and memory Tfh populations, while in gut ILC3 it supports tissue residency by transcriptionally upregulating Hexokinase-2 to enable glycolytic metabolic adaptation [PMID:31732165, PMID:34623911, PMID:38677292]. In the nucleus of T-ALL cells, TOX2 forms a repressive complex with TOX, the corepressor LCOR, and the deacetylase HDAC3 to suppress HAVCR2 (TIM3) transcription, with its nuclear retention regulated by SIRT1-mediated deacetylation and TBK1-dependent phosphorylation [PMID:39080376].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing TOX2 as a transcription factor active in early lymphocyte development, this work showed that TOX2 directly upregulates TBX21 to control NK cell developmental transitions, a function independent of ETS-1.\",\n      \"evidence\": \"shRNA knockdown and T-BET rescue in cord blood CD34+ progenitor-derived NK cell differentiation assays\",\n      \"pmids\": [\"25352127\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding of TOX2 to the TBX21 promoter was not demonstrated by ChIP\", \"Role of TOX2 in mature NK cell function beyond developmental transitions is unknown\", \"Whether TOX2 controls NK development in vivo was not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Two studies established TOX2 as a key transcriptional regulator in CD4+ and CD8+ T cell fate decisions: in CD8+ T cells, TOX2 cooperates with TOX downstream of NFAT to enforce the exhaustion program, while in CD4+ T cells, TOX2 directly binds the Bcl6 locus to initiate a feed-forward loop driving Tfh differentiation.\",\n      \"evidence\": \"Tox/Tox2 double-KO CAR T cells with ATAC-seq, flow cytometry, and in vivo tumor models (CD8+ exhaustion); ChIP-seq, ATAC-seq, and Tox2−/− mice with ectopic overexpression (Tfh differentiation)\",\n      \"pmids\": [\"31152140\", \"31732165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOX2 has distinct or redundant chromatin targets compared to TOX was not resolved\", \"The precise DNA-binding specificity of TOX2's HMG-box domain versus TOX was not defined\", \"Relative contributions of TOX versus TOX2 to exhaustion versus memory programs remained unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extending the Tfh role, TOX2 was shown to be required not only for initial Tfh differentiation but also for maintaining germinal center Tfh identity and generating durable memory Tfh populations capable of recall responses.\",\n      \"evidence\": \"Tox2-deficient mice with reimmunization and heterologous influenza infection; Tox2 overexpression in human GC Tfh cells preventing TH1 conversion\",\n      \"pmids\": [\"34623911\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TOX2 chromatin targets in GC Tfh versus pre-Tfh were not distinguished\", \"Whether TOX2 collaborates with the same or different cofactors in GC Tfh maintenance is unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Two studies reframed TOX2's functional versatility: in NKTL, RUNX3 drives TOX2 expression through a super-enhancer to activate the oncogenic effector PRL-3; separately, in human CAR T cells, loss of TET2 elevates TOX2 expression and TOX2 promotes central memory T cell differentiation by binding TCM gene promoters, distinguishing its memory-promoting role from its exhaustion-associated function.\",\n      \"evidence\": \"ChIP-PCR, CRISPR-dCas9 SE interference, xenograft models (NKTL); TET2 knockdown with ATAC-seq, TOX2 ChIP-seq, shRNA in human CAR T cells (TCM)\",\n      \"pmids\": [\"37032358\", \"37467321\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the RUNX3–TOX2 super-enhancer axis operates in non-malignant lymphocytes is untested\", \"How TOX2 discriminates between memory versus exhaustion target gene sets is mechanistically undefined\", \"The relationship between TET2-mediated demethylation at the TOX2 locus and TOX2 protein activity is correlative\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two advances revealed TOX2 functions in innate lymphoid cells and in leukemic gene repression: in gut ILC3, TOX2 promotes tissue residency by transcriptionally activating Hexokinase-2 to support glycolytic metabolism required for protein translation; in T-ALL, nuclear TOX2 forms a repressive complex with TOX, LCOR, and HDAC3 to suppress HAVCR2 (TIM3), with nuclear-cytoplasmic shuttling controlled by SIRT1-mediated deacetylation and TBK1 phosphorylation.\",\n      \"evidence\": \"Tox2−/− mice with scRNA-seq, HK2 rescue, and Citrobacter rodentium infection (ILC3); Co-IP, luciferase reporter, shRNA, subcellular fractionation, and xenograft model (T-ALL)\",\n      \"pmids\": [\"38677292\", \"39080376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the TOX2–LCOR–HDAC3 repressive complex operates in normal T cells or is specific to T-ALL is unknown\", \"The acetylation sites on TOX2 targeted by SIRT1 have not been mapped\", \"Whether TOX2's glycolytic reprogramming role extends to other tissue-resident lymphocyte populations is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include how TOX2's HMG-box domain selects among its diverse target loci in different lineage contexts, the structural basis for TOX2–TOX heterodimerization, and whether TOX2 post-translational modifications (acetylation, phosphorylation) gate its transcriptional outputs in non-malignant lymphocyte subsets.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of TOX2 or the TOX–TOX2 complex exists\", \"Genome-wide binding maps in primary cells lack functional validation of individual target genes\", \"Post-translational regulation of TOX2 has only been studied in T-ALL cells\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 5, 7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 3, 6]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 2, 5, 7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 7]}\n    ],\n    \"complexes\": [\n      \"TOX–TOX2–LCOR–HDAC3 repressive complex\"\n    ],\n    \"partners\": [\n      \"TOX\",\n      \"BCL6\",\n      \"LCOR\",\n      \"HDAC3\",\n      \"SIRT1\",\n      \"TBK1\",\n      \"RUNX3\",\n      \"TBX21\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}